Today: 3 February 2026
Subscribe
Browse Category

NASDAQ:IOT News 3 February 2026

Why Samsara (IOT) stock is on watch: Canada expansion and March 5 earnings date

Why Samsara (IOT) stock is on watch: Canada expansion and March 5 earnings date

New York, Feb 3, 2026, 08:47 EST — Premarket Samsara shares dipped roughly 0.3% to $26.33 in Tuesday’s premarket. On Monday, the stock closed down 5.8% at $26.41. (Investing) The drop hinges on two updates from the company that came out just a day apart: a broader push into Canada and a confirmed date for the upcoming earnings release. Each…
3 February 2026
·····

Stock Market Today

  • Novo Nordisk Forecasts Decline in 2026 Sales and Profit Driven by U.S. Market Challenges
    February 3, 2026, 12:41 PM EST. Novo Nordisk warned of falling sales and profit growth in 2026, citing lower prices in the U.S. and loss of exclusivity for its leading GLP-1 drugs Wegovy and Ozempic in China, Brazil, and Canada. Its U.S. shares plunged 13.7% after the announcement. The Danish drugmaker, which leads the weight loss drug market, saw 2025 sales grow 10% with operating profit up 6%, but expects a 5-13% decline next year. Novo plans to expand Wegovy and introduce a higher dose globally, aiming to counter intense competition, particularly from Eli Lilly. Investors remain cautious as the company navigates price pressures and the rollout of oral GLP-1 treatments.
Go toTop